Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit-Reference-Cited by-同舟云学术

Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit

Published:2016-03-14 Issue:5 Volume:12 Page:614-622
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Molinuevo José L.¹,Cami Jordi²,Carné Xavier³,Carrillo Maria C.⁴,Georges Jean⁵,Isaac Maria B.⁶,Khachaturian Zaven⁷,Kim Scott Y.H.⁸,Morris John C.⁹,Pasquier Florence¹⁰,Ritchie Craig¹¹,Sperling Reisa¹²,Karlawish Jason¹³

Affiliation:

1. Barcelonaβeta Brain Research Center Pasqual Maragall Foundation Barcelona Spain

2. Pompeu Fabra University and Pasqual Maragall Foundation Barcelona Spain

3. Clinical Pharmacology Department Hospital Clinic and IDIBAPS Barcelona Spain

4. Medical & Scientific Relations Alzheimer's Association Chicago IL USA

5. Alzheimer Europe Luxembourg Luxembourg

6. European Medicines Agency (EMA) London UK

7. The Campaign to Prevent Alzheimer by 2020 (PAD2020) Potomac MD USA

8. Department of Bioethics, Clinical Center National Institutes of Health Bethesda MD USA

9. Washington University School of Medicine St Louis MO USA

10. Inserm 1171 Université Lille2, CHU, Memory Centre Lille Lille France

11. Centre for Clinical Brain Sciences University of Edinburgh Edinburgh UK

12. Center for Alzheimer Research and Treatment Brigham and Women's Hospital, Harvard Medical School Boston MA USA

13. Department of Medicine, Perelman School of Medicine University of Pennsylvania Philadelphia PA USA

Funder

European Federation of Pharmaceutical Industries and Associations

Roche

Novartis

Eli Lilly and Company

Innovative Medicines Initiative

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2016.01.009

Reference66 articles.

1. Alzheimer disease therapy—moving from amyloid-β to tau

2. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

3. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria

4. Revising the definition of Alzheimer's disease: a new lexicon

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Informing Alzheimer’s Biomarker Communication: Concerns and Understanding of Cognitively Unimpaired Adults During Amyloid Results Disclosure;The Journal of Prevention of Alzheimer's Disease;2024

2. Ethical Issues of Primary and Secondary Dementia Prevention;GeroPsych;2023-11

3. “I Want to Know Everything ... ”: The Return of Research Results and the Importance of Transparency in the Acceptability of Lumbar Punctures for African American Older Adults;Journal of Alzheimer's Disease;2023-09-12

4. Biomarkers of aging;Science China Life Sciences;2023-04-11

5. Ethical issues when using digital biomarkers and artificial intelligence for the early detection of dementia;WIREs Data Mining and Knowledge Discovery;2023-02-19